Bausch Health
260 hedge funds and large institutions have $1.81B invested in Bausch Health in 2022 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 50 increasing their positions, 104 reducing their positions, and 64 closing their positions.
11.15% more ownership
Funds ownership: 67.96% → 79.11% (+11%)
6% more capital invested
Capital invested by funds: $1.7B → $1.81B (+$103M)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
8% less funds holding
Funds holding: 283 → 260 (-23)
27% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 64
47% less call options, than puts
Call options by funds: $71.2M | Put options by funds: $133M
52% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 104
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$91M |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$55.9M |
| 3 |
N
Natixis
Paris,
France
|
+$54.6M |
| 4 |
Goldman Sachs
New York
|
+$52.9M |
| 5 |
IG
ING Group
Amsterdam,
Netherlands
|
+$47.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$32.6M |
| 2 |
SPC
Silver Point Capital
Greenwich,
Connecticut
|
-$20.5M |
| 3 |
D.E. Shaw & Co
New York
|
-$14.1M |
| 4 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$10.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$7M |
BHC Hedge Fund Activity: Q4 2022 in Review
260 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q4 2022, worth a combined $1.81B — up 6% from $1.7B a quarter earlier.
Sellers outnumbered buyers: 64 funds closed out of BHC and 47 opened new positions — a net loss of 17 holders — while 104 trimmed existing stakes and 50 added.
The largest buyer was National Bank of Canada, adding an estimated $91M. The largest seller was Nomura Holdings, cutting an estimated $32.6M.
- 260 institutional investors held Bausch Health (BHC) as of Q4 2022, down from 283 in Q3 2022.
- Funds reported $1.81B of Bausch Health stock for Q4 2022, up 6% quarter-over-quarter.
- 47 funds opened new Bausch Health positions in Q4 2022 and 64 closed out, a net change of -17 holders.
- The largest Bausch Health buyer in Q4 2022 was National Bank of Canada, an estimated $91M added.
- The largest Bausch Health seller in Q4 2022 was Nomura Holdings, an estimated $32.6M sold.
Based on aggregated 13F filings for Q4 2022.